STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Clinical trials for STAGE IV PANCREATIC CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental vaccine targets Hard-to-Treat pancreatic tumors
Disease control OngoingThis early-phase study tested a special vaccine (PANVAC) given directly into the tumor plus under the skin, along with a drug that boosts immune cells (sargramostim), in 18 people with advanced pancreatic cancer that could not be removed by surgery. The main goal was to find the …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:59 UTC
-
Experimental drug cocktail targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a combination of two targeted drugs (vismodegib and erlotinib) with or without standard chemotherapy (gemcitabine) in people with advanced pancreatic cancer or other solid tumors that cannot be removed by surgery. The main goal is to find the safest d…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
Triple-Drug cocktail targets Hard-to-Treat pancreatic cancer
Disease control OngoingThis early-phase study tested a combination of three drugs (gemcitabine, dasatinib, and erlotinib) in 19 people with advanced pancreatic cancer that had spread or could not be removed by surgery. The main goal was to find the safest dose and check for side effects. Researchers al…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug duo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a combination of two drugs, guadecitabine and durvalumab, in people with advanced liver, pancreatic, bile duct, or gallbladder cancer that has spread. The goal is to find the best dose and see if the combination is safe and can shrink tumors. About 55…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Could a diabetes drug and supplements boost chemo for pancreatic cancer?
Disease control OngoingThis early-phase study tests whether adding the diabetes drug metformin and a specific dietary supplement mix to standard chemotherapy is safe and feasible for people with pancreatic cancer that cannot be removed by surgery. The supplement includes ingredients like curcumin, vita…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs, cediranib and olaparib, in people with advanced or inoperable solid tumors, including certain breast, lung, and pancreatic cancers. The goal is to see if the combo can shrink tumors or slow their growth by blocking enzymes that cancer …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
Experimental pill aims to boost radiation against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it makes tumor cells more sensitive to radiation therapy. Nineteen participants with cancer…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC